2026-07-06 Incyte Corporation

Share Article

The stock underperformed expectations, opening lower and continuing to decline. Although it rebounded during the session, it failed to break above yesterday’s closing price. I sold half of my position to reduce risk.

You might also like

Strategy 1

Strategy 1 US Value Stock Screener: Average Volume 30 Day > 20M Price x Volume > 10M Market Cap >= 200 B Price >= $20

2026-04-28 Ventas, Inc.

Bought Ventas, Inc. as it somewhat meets Strategy 1 criteria.The stock has been either consolidating sideways or in a short-term downtrend. 👍 Positives MACD has